Opportunity ID: 271929

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-15-099
Funding Opportunity Title: Reductions in Illicit Drug Use and Functional Outcomes (R21/R33)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jan 23, 2015
Last Updated Date: Apr 12, 2017
Original Closing Date for Applications: Sep 07, 2017
Current Closing Date for Applications: Jan 07, 2018
Archive Date: Feb 06, 2018
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
Independent school districts
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Special district governments
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for Phased Innovation (R21/R33) projects to determine whether reductions in illicit drug use are associated with positive changes in health-related and other functional outcomes in individuals with substance use disorders (SUDs). Functional outcomes include, for example, reductions in morbidity, mortality, criminal justice involvement, overall healthcare expenditures. This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by possible transition to expanded research support (R33 phase). The transition to the R33 phase will be determined by NIH program evaluation of successful achievement of the milestones set for the R21 phase. The ultimate goal of this FOA is to provide evidence that will enable regulatory authorities to accept reductions in illicit drug use as a valid outcome measure in clinical trials of pharmacotherapies for the treatment of SUDs.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-15-099.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Updated expiration date in accordance with NOT-DA-17-023 Apr 12, 2017
Apr 12, 2017

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-15-099
Funding Opportunity Title: Reductions in Illicit Drug Use and Functional Outcomes (R21/R33)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jan 23, 2015
Last Updated Date: Apr 12, 2017
Original Closing Date for Applications: Sep 07, 2017
Current Closing Date for Applications: Jan 07, 2018
Archive Date: Feb 06, 2018
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
Independent school districts
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Special district governments
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for Phased Innovation (R21/R33) projects to determine whether reductions in illicit drug use are associated with positive changes in health-related and other functional outcomes in individuals with substance use disorders (SUDs). Functional outcomes include, for example, reductions in morbidity, mortality, criminal justice involvement, overall healthcare expenditures. This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by possible transition to expanded research support (R33 phase). The transition to the R33 phase will be determined by NIH program evaluation of successful achievement of the milestones set for the R21 phase. The ultimate goal of this FOA is to provide evidence that will enable regulatory authorities to accept reductions in illicit drug use as a valid outcome measure in clinical trials of pharmacotherapies for the treatment of SUDs.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-15-099.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-15-099
Funding Opportunity Title: Reductions in Illicit Drug Use and Functional Outcomes (R21/R33)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 12, 2017
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Sep 07, 2017
Archive Date: Oct 08, 2017
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: County governments
Small businesses
State governments
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for Phased Innovation (R21/R33) projects to determine whether reductions in illicit drug use are associated with positive changes in health-related and other functional outcomes in individuals with substance use disorders (SUDs). Functional outcomes include, for example, reductions in morbidity, mortality, criminal justice involvement, overall healthcare expenditures. This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by possible transition to expanded research support (R33 phase). The transition to the R33 phase will be determined by NIH program evaluation of successful achievement of the milestones set for the R21 phase. The ultimate goal of this FOA is to provide evidence that will enable regulatory authorities to accept reductions in illicit drug use as a valid outcome measure in clinical trials of pharmacotherapies for the treatment of SUDs.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-15-099.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-C FORMS-C PKG00212183 May 16, 2015 May 07, 2016 View
FORMS-D Use for due dates on or after May 25, 2016 PKG00222690 May 16, 2016 Jan 07, 2018 View

Package 1

Mandatory forms

271929 RR_SF424_2_0-2.0.pdf

271929 PHS398_ResearchPlan_2_0-2.0.pdf

271929 PHS398_CoverPageSupplement_2_0-2.0.pdf

271929 RR_Budget_1_3-1.3.pdf

271929 RR_KeyPersonExpanded_2_0-2.0.pdf

271929 RR_OtherProjectInfo_1_3-1.3.pdf

271929 PerformanceSite_2_0-2.0.pdf

Optional forms

271929 PlannedReport-1.0.pdf

271929 PHS398_CumulativeInclusionReport-1.0.pdf

271929 RR_SubawardBudget30_1_3-1.3.pdf

Package 2

Mandatory forms

271929 RR_SF424_2_0-2.0.pdf

271929 PHS398_CoverPageSupplement_3_0-3.0.pdf

271929 RR_OtherProjectInfo_1_3-1.3.pdf

271929 PerformanceSite_2_0-2.0.pdf

271929 RR_KeyPersonExpanded_2_0-2.0.pdf

271929 RR_Budget_1_3-1.3.pdf

271929 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

271929 RR_SubawardBudget30_1_3-1.3.pdf

271929 PHS_Inclusion_Enrollment_Report-1.0.pdf

271929 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T08:37:44-05:00

Share This Post, Choose Your Platform!

About the Author: